Suppression of lysophosphatidic acid and lysophosphatidylcholine formation in the plasma in vitro: proposal of a plasma sample preparation method for laboratory testing of these lipids.

[1]  H. Arai,et al.  Measurement of lysophospholipase D/autotaxin activity in human serum samples. , 2007, Clinical biochemistry.

[2]  A. Lumsden,et al.  Lysophosphatidylcholine and secretory phospholipase A2 in vascular disease: mediators of endothelial dysfunction and atherosclerosis. , 2006, Medical science monitor : international medical journal of experimental and clinical research.

[3]  H. Ikeda,et al.  Platelet release of beta-thromboglobulin and platelet factor 4 and serotonin in plasma samples. , 2005, Clinical biochemistry.

[4]  B. Giepmans,et al.  The ins and outs of lysophosphatidic acid signaling , 2004, BioEssays : news and reviews in molecular, cellular and developmental biology.

[5]  Rebecca Sutphen,et al.  Lysophospholipids are potential biomarkers of ovarian cancer. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[6]  T. Iwasaka,et al.  High-performance liquid chromatographic method with column-switching and post-column reaction for determination of serotonin levels in platelet-poor plasma. , 2004, Clinical biochemistry.

[7]  H. Suh,et al.  Therapeutic effects of lysophosphatidylcholine in experimental sepsis , 2004, Nature Network Boston.

[8]  N. Wang,et al.  Serum lysophosphatidic acid concentrations measured by dot immunogold filtration assay in patients with acute myocardial infarction , 2003, Scandinavian journal of clinical and laboratory investigation.

[9]  D. Baker,et al.  Subtype-Selective Antagonists of Lysophosphatidic Acid Receptors Inhibit Platelet Activation Triggered by the Lipid Core of Atherosclerotic Plaques , 2003, Circulation.

[10]  G. Mills,et al.  The emerging role of lysophosphatidic acid in cancer , 2003, Nature Reviews Cancer.

[11]  S. Imamura,et al.  A novel colorimetric assay for the determination of lysophosphatidic acid in plasma using an enzymatic cycling method. , 2003, Clinica chimica acta; international journal of clinical chemistry.

[12]  G. Schmitz,et al.  Plasma ceramide and lysophosphatidylcholine inversely correlate with mortality in sepsis patients Published, JLR Papers in Press, January 16, 2003. DOI 10.1194/jlr.M200401-JLR200 , 2003, Journal of Lipid Research.

[13]  R. Taguchi,et al.  Serum Lysophosphatidic Acid Is Produced through Diverse Phospholipase Pathways* , 2002, The Journal of Biological Chemistry.

[14]  K. Fukuzawa,et al.  Identification of Human Plasma Lysophospholipase D, a Lysophosphatidic Acid-producing Enzyme, as Autotaxin, a Multifunctional Phosphodiesterase* , 2002, The Journal of Biological Chemistry.

[15]  G. Mills,et al.  Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production , 2002, The Journal of cell biology.

[16]  Y. Soda,et al.  An enzymatic assay for lysophosphatidylcholine concentration in human serum and plasma. , 2002, Clinical biochemistry.

[17]  Daniel L Baker,et al.  Plasma lysophosphatidic acid concentration and ovarian cancer. , 2002, JAMA.

[18]  M. Macey,et al.  Evaluation of the anticoagulants EDTA and citrate, theophylline, adenosine, and dipyridamole (CTAD) for assessing platelet activation on the ADVIA 120 hematology system. , 2002, Clinical chemistry.

[19]  Duane D. Miller,et al.  Direct quantitative analysis of lysophosphatidic acid molecular species by stable isotope dilution electrospray ionization liquid chromatography-mass spectrometry. , 2001, Analytical biochemistry.

[20]  A. Jonas.  Lecithin cholesterol acyltransferase. , 2000, Biochimica et biophysica acta.

[21]  P. Valet,et al.  A simple and highly sensitive radioenzymatic assay for lysophosphatidic acid quantification. , 2000, Journal of lipid research.

[22]  R. Taguchi,et al.  Two-dimensional analysis of phospholipids by capillary liquid chromatography/electrospray ionization mass spectrometry. , 2000, Journal of mass spectrometry : JMS.

[23]  Y Chen,et al.  Evaluation of Plasma Lysophospholipids for Diagnostic Significance Using Electrospray Ionization Mass Spectrometry (ESI‐MS) Analyses , 2000, Annals of the New York Academy of Sciences.

[24]  M. Okita,et al.  Abnormal serum lysophospholipids in multiple myeloma patients , 1999, Lipids.

[25]  K. Fukuzawa,et al.  Metal-lon stimulation and inhibition of lysophospholipase D which generates bioactive lysophosphatidic acid in rat plasma , 1998, Lipids.

[26]  M Markman,et al.  Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers. , 1998, JAMA.

[27]  H. Maegawa,et al.  Oxidized lipoproteins found in patients with NIDDM stimulate radical-induced monocyte chemoattractant protein-1 mRNA expression in cultured human endothelial cells , 1997, Diabetologia.

[28]  G. Mills,et al.  Elevated levels and altered fatty acid composition of plasma lysophosphatidlycholine(lysoPC) in ovarian cancer patients , 1997, International journal of cancer.

[29]  Y. Snitko,et al.  High specificity of human secretory class II phospholipase A2 for phosphatidic acid. , 1997, The Biochemical journal.

[30]  I. Fahrenfort,et al.  The bioactive phospholipid lysophosphatidic acid is released from activated platelets. , 1993, The Biochemical journal.

[31]  D. Steinberg,et al.  Role of oxidized low density lipoprotein in atherogenesis. , 1991, The Journal of clinical investigation.

[32]  J. M. Sequeira,et al.  Lysophosphatidylcholine accumulation in ischemic human myocardium. , 1993, The Journal of laboratory and clinical medicine.

[33]  M. Cybulsky,et al.  Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. , 1992, The Journal of clinical investigation.

[34]  L. Liotta,et al.  Identification, purification, and partial sequence analysis of autotaxin, a novel motility-stimulating protein. , 1992, The Journal of biological chemistry.

[35]  A. Marcus,et al.  Inhibition of human platelet reactivity by endothelium-derived relaxing factor from human umbilical vein endothelial cells in suspension: blockade of aggregation and secretion by an aspirin-insensitive mechanism. , 1991, Blood.

[36]  P. Corr,et al.  A sensitive, radiometric assay for lysophosphatidylcholine. , 1990, Analytical biochemistry.

[37]  J. Gerrard,et al.  Identification of the molecular species of lysophosphatidic acid produced when platelets are stimulated by thrombin. , 1989, Biochimica et biophysica acta.

[38]  D. Steinberg,et al.  Lysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherogenesis. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[39]  Tokumura Akira,et al.  Involvement of lysophospholipase D in the production of lysophosphatidic acid in rat plasma. , 1986 .

[40]  S. Robins,et al.  Origin of plasma lysophosphatidylcholine: evidence for direct hepatic secretion in the rat. , 1985, The Journal of laboratory and clinical medicine.

[41]  G. Contant,et al.  Heparin inactivation during blood storage: its prevention by blood collection in citric acid, theophylline, adenosine, dipyridamole-C.T.A.D. mixture. , 1983, Thrombosis research.

[42]  K. Kaplan,et al.  Plasma levels of beta-thromboglobulin and platelet factor 4 as indices of platelet activation in vivo , 1981 .

[43]  R. Demel,et al.  High performance liquid chromatographic separation and direct ultraviolet detection of phospholipids. , 1977, Biochimica et biophysica acta.

[44]  E. Salzman,et al.  CYCLIC 3′,5′‐ADENOSINE MONOPHOSPHATE IN HUMAN BLOOD PLATELETS IV. REGULATORY ROLE OF CYCLIC AMP IN PLATELET FUNCTION * , 1972, Annals of the New York Academy of Sciences.

[45]  J. Smith,et al.  The influence on platelet aggregation of drugs that affect the accumulation of adenosine 3':5'-cyclic monophosphate in platelets. , 1971, The Biochemical journal.